Colgate Palmolive CO Form 4 insider transactions

Colgate-Palmolive's EVP and Controller, Malcolm Gregory, has reported scheduled dispositions of 241 shares of common stock in September 2025 to cover tax liabilities from restricted stock unit vesting.

Colgate-Palmolive's Chief Human Resources Officer, Sally Massey, disposed of 1,116 shares of common stock to cover tax liabilities related to restricted stock unit vesting.

Colgate-Palmolive Vice Chair Prabha Parameswaran disposed of 1,678 shares of common stock to cover tax liabilities related to restricted stock unit vesting.

Colgate-Palmolive's Chief Financial Officer, Stanley J. Sutula III, filed a Form 4 indicating future planned dispositions of common stock in September 2025 to cover tax liabilities from restricted stock unit vesting.

Colgate-Palmolive's COO, Panagiotis Tsourapas, reported future share withholdings to cover tax liabilities from restricted stock unit vesting.

Colgate-Palmolive CEO Noel R. Wallace disposed of common stock to cover tax liabilities related to restricted stock unit vesting.

Colgate-Palmolive's Chairman, President, and CEO, Noel R. Wallace, was granted substantial restricted stock units and stock options as part of the company's incentive compensation plan.

Colgate-Palmolive's COO, Panagiotis Tsourapas, was granted restricted stock units and stock options as part of his compensation package.

Colgate-Palmolive's Chief Financial Officer, Stanley J. Sutula III, was granted 8,328 restricted stock units and 57,661 stock options as part of the company's incentive compensation plan.

Colgate-Palmolive's Vice Chair, Prabha Parameswaran, was granted restricted stock units and stock options as part of the company's incentive compensation plan.

Colgate-Palmolive's Chief Human Resources Officer, Sally Massey, was granted 3,450 restricted stock units and 23,888 stock options as part of the company's incentive compensation plan.

Colgate-Palmolive's Chief Growth Officer, John Hazlin, received a substantial equity award comprising restricted stock units and stock options.

Colgate-Palmolive's EVP and Controller, Malcolm Gregory, was granted restricted stock units and stock options as part of the company's incentive plan.

Colgate-Palmolive's COO, Americas, Shane Grant, was granted 3,569 restricted stock units and 24,712 stock options as part of the company's incentive compensation plan.

Colgate-Palmolive's Chief Legal Officer and Secretary, Jennifer Daniels, was granted restricted stock units and stock options as part of the company's incentive compensation plan.

Colgate-Palmolive Company Director Lorrie M. Norrington acquired 292 shares of common stock by deferring a portion of her annual cash retainer into a stock unit account.

Colgate-Palmolive Company Director Brian Newman acquired 208 shares of common stock on July 1, 2025, by deferring a portion of his annual cash retainer into a stock unit account.

Colgate-Palmolive Company Director John P. Bilbrey acquired 264 shares of common stock at $89.91 per share through a deferred compensation plan.

Colgate-Palmolive Company's COO, Americas, Shane Grant, was granted 90,000 shares of common stock as a restricted stock unit award.

Sally Massey, Chief Human Resources Officer at Colgate-Palmolive, reported selling 2,250 shares of common stock on May 15, 2025.

Director Kimberly A. Nelson received a stock grant and option award from Colgate-Palmolive on May 12, 2025, according to a Form 4 filing with the SEC.

Director Lorrie M Norrington reports receiving a stock grant and stock option grant from Colgate-Palmolive on May 12, 2025.

Director Brian Newman reports acquisition of stock and stock options from Colgate-Palmolive's incentive compensation plan.

Director Martina Hundmejean reports acquisition of stock and stock options in Colgate-Palmolive under the company's incentive compensation plan.

Director Lisa Edwards reports receiving an annual stock grant and stock option award from Colgate-Palmolive on May 12, 2025.

Director Martin Harris acquired 1,514 shares of common stock and options to purchase 2,272 shares of common stock from Colgate-Palmolive on May 12, 2025, as part of the company's incentive compensation plan.

Director Steven A. Cahillane reports receiving stock and option grants from Colgate-Palmolive on May 12, 2025.

Director John T. Cahill received a stock grant of 2,019 shares and stock options for 2,272 shares of Colgate-Palmolive common stock on May 12, 2025.

Director John P. Bilbrey reports acquisition of stock and options in Colgate-Palmolive through an annual director grant.

Director Brian Newman reports acquiring and disposing of Colgate-Palmolive stock, including shares acquired through a deferred compensation plan and shares held by a family trust.